Mary is a Specialist Consultant with a focus in Strategy & Program Leadership located in Boston, MA with more than 10 years of experience in life science-based corporate transactions and cross-functional project management. She has experience in strategic advisory for the value proposition of early stage development programs and her consulting experience has been focused on scientific due diligence, market landscapes, and training junior colleagues in competitive intelligence. Recent client work has included preparation of clients for financing or M&A discussions through virtual data room setup, confidential pitch deck overhaul, and comparable analyses to solidify company valuation.

Prior to joining Halloran, Mary worked at the investment banking firm Locust Walk where she leveraged her scientific training to be an in-house subject matter expert on the assets/technology platforms undergoing mergers & acquisitions or out-licensing transactions for an array of clients. She is a FINRA registered investment banking representative with Series 79 and 63 licenses.

Education:
Boston University, Doctor of Philosophy of Bioinorganic Chemistry (PhD)
Boston University, Master of Arts, Bioinorganic Chemistry
Saint Joseph’s University, Bachelor of Science, Chemistry

Licenses:
FINRA-regulated Series 79 Investment Banking Top-Off License (issued 2021; expires 2023)
FINRA-regulated Series 63 Uniform Securities Agent State License (issued 2020; no expiration date)
FINRA-regulated Securities Industry Essentials (issued 2020; no expiration date)